Objectives: During orthodontic tooth movement (OTM), human periodontal ligament fibroblasts (hPDLFs) sense, and respond to mechanical forces. Since the molecular constituents involved in these processes are not fully elucidated, the objective of the present study was to identify further key molecules of the cellular strain response. Materials and Methods: Primary hPDLFs were strained with a static equiaxial strain of 2.5 per cent for 15 minutes, 1 hour, 6 hours, and 24 hours. Western blot (WB) and indirect immunofluorescence (IIF) analyses were performed to investigate the quantity and activation state of proteins involved in mechanotransduction, namely extracellular signal-regulated kinase (ERK) 1/2 and yesassociated protein (YAP). On the cell behavioural level, proliferation was assessed by the marker of proliferation KI-67. Results: In response to the applied strain, an early decline of phosphorylated and thus activated ERK1/2 was observed, followed by a mild recovery. Furthermore, both WB and IIF analyses revealed a modulation of nuclear YAP localisation. Concomitant with the modulation of YAP, the applied strain evoked an early increase in nuclear KI-67 amount, followed by a continuous decrease. Limitations: Consecutive studies will focus on scrutinising the suggested relationship between YAP and proliferation in response to static strain. Conclusions: Our findings provide evidence of ERK1/2 and YAP being biomechanically responsive molecular players in the context of OTM, among which YAP rather than ERK1/2 seems to be mechanistically interrelated with proliferation. Furthermore, the molecular and cell behavioural strain-induced early modulations may point to an involvement of the investigated molecules in the initial and the following lag phase of OTM.
Introduction
In addition to intermittent forces exerted on the periodontium during chewing, swallowing, or speech, the periodontium is targeted by biomechanical forces during orthodontic tooth movement (OTM) (1) . A major periodontal constituent to be addressed by biomechanical forces is the periodontal ligament (PDL) (2) . The PDL is a specialized soft connective tissue, which mainly comprises of extracellular matrix (ECM), particularly collagen type-1 (3). It is crucial for tooth anchorage and essential for orthodontic treatment, as its absence renders tooth movement impossible (4) . By applying biomechanical forces, the PDL is strained at the tension side, leading to deformation of the periodontal ECM. This deformation is sensed and transduced into intracellular signals by PDL fibroblasts (PDLFs), which are the main cell source of ECM turnover (3, 5) .
In response to the biomechanical forces, PDLFs react with a specific cell behavioural answers, e.g. proliferation (6) . Proliferation is essential for the remodelling processes in the periodontium, occurring during the initial phase of OTM (7, 8) . A reliable biomarker to detect proliferating cells is the nuclear marker of proliferation KI-67, as it characterizes the growth fraction of a given cell population (9, 10) .
One of the known key players in mechanotransduction represents the mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase (ERK) 1/2, also known as p44/42 (11) . In response to biomechanical forces, ERK1/2 can be modulated in its activity state (12, 13) . Its activation is reflected by phosphorylation at threonine residue 202/204 (T202/204), which is catalysed by upstream kinases of the MAPK pathway. Subsequently, ERK1/2 enters the nucleus and modulates gene expression via phosphorylation of downstream targets, e.g. molecules, regulating proliferation (14) . One of the potential cell behavioural answers to biomechanical forces, regulated by ERK1/2, is the modulation of proliferation (15) .
Recently the transcriptional co-activator yes-associated protein (YAP) has been identified to be important in mechanotransduction (16, 17) . YAP is part of the canonical Hippo signalling pathway. It acts as both mechanosensor and mechanotransducer in various cell types, by sensing biomechanical forces and converting them into biochemical signals via translocation (17) . In its phosphorylated and thus inactivated state, YAP is present in the cytoplasm (18) . Upon stimulation, YAP becomes dephosphorylated and translocates into the nucleus. In this activated state, YAP binds to transcriptional enhancers, thereby regulating the expression of various genes that are involved in proliferation, survival, and migration (19) .
During the past, the concept of mechanotransduction has also been applied to PDLFs. However, the identification and putative interplay of molecular key players involved in mechanotransduction in PDLFs have not yet been fully elucidated. Therefore, we mimicked OTM-related strain forces by in vitro subjection of primary human PDLFs (hPDLFs) to a static equiaxial strain of 2.5 per cent for various time periods, and analysed the quantity and activity state of the putative key players. In particular, we focused on whether ERK1/2 and/or YAP are associated with a cell behavioural response, as represented by proliferation.
Materials and methods

Cell culture
Primary hPDLFs were generously provided by PD Dr. Susanne Proksch (Department of Operative Dentistry and Periodontology, University Medical Center Freiburg, Germany) and derived from the ligament of non-carious human wisdom teeth with healthy periodontium, extracted from a male donor (14 years) for orthodontic reasons with written informed consent. All experiments were carried out in accordance to the guidelines of the World Medical Association Declaration of Helsinki and were approved by the Committee of Ethics of the Medical Faculty of the Albert LudwigsUniversity Freiburg, Germany (vote number 153/15). In detail, PDL was scraped off from the middle third of the tooth roots. Tissue specimens were rinsed with 10 per cent iodine, thoroughly washed and minced. Tissue fragments were plated as explants in MEMalpha (Life Technologies Ltd, Paisley, UK) supplemented with 10 per cent fetal calf serum (FCS; Biochrom, Berlin, Germany), 2 mM L-alanyl-L-glutamine (Invitrogen, Karlsruhe, Germany), 1 per cent amphotericin and 1 per cent kanamycin (Sigma Aldrich, Taufkirchen, Germany), which was exchanged every 2-3 days until cell outgrowth. The cells were characterized by flow cytometry, ECM mineralization and gene expression analysis (personal communication and manuscript in preparation). For further experiments, cells were grown in Dulbecco's Modified Eagle Medium (Life Technologies Ltd) supplemented with 10 per cent FCS, 2 mM l-alanyl-l-glutamine and 0.1 mg/ml kanamycin in humidified atmosphere with 5 per cent CO 2 at 37°C. For the strain experiments, cells were used at passages five to eight.
Strain application
For each experiment, 1 × 10 4 hPDLFs per cm 2 were plated in flexible silicone bottomed six-well plates coated with collagen type I (Flexcell International Corporation, Hillsborough, USA), which facilitates the adhesion of hPDLFs by mimicking the ECM of the PDL (3). Cells were cultivated for 3 days, reaching a confluency of 70-80 per cent. Ninety minutes prior to mechanical strain application, treatment cells were placed in the base plate and unstrained control cells were placed aside, as an effect on mechanotransduction by handling the cells has been noticed (13) . Cells were subjected to static equiaxial strain of 2.5 per cent for 15 minutes, 1 hour, 6 hours, and 24 hours with a Flexercell Strain Unit (Modell FX5000-T, Dunn Labortechnik GmbH, Asbach, Germany). Static tensile strain of 2.5 per cent is commonly applied and identified to mimic forces which occur during OTM at the tension side using fixed appliances (20) . The mentioned time periods were chosen as they are known to reflect initial stages of applied mechanical forces during orthodontic treatment (21) . Cells grown on unstrained Bioflex culture plates were used as controls and harvested together with the 6 hours time point.
Primary antibodies
For both WB and IIF analyses primary antibodies against ERK1/2 (rabbit polyclonal; 4695S; Cell Signaling, Danvers, USA), phosphorylated ERK1/2 at T202/204 (rabbit polyclonal, Cell Signaling), YAP (mouse monoclonal, Santa Cruz, California, USA), and KI-67 (rabbit monoclonal, abcam, Cambridge, UK) were used.
Western blot
After the strain application, hPDLFs were rinsed twice with 2 ml ice-cold phosphate-buffered saline (PBS, Thermo Fisher Scientific, Braunschweig, Germany). Either whole cell extracts or separated cytoplasmic and nuclear extracts were used, depending on the analysed protein. To obtain whole cell extracts, cells were lysed for 10 minutes on ice with 250 µl RIPA buffer (Sigma Aldrich) supplemented with cOmplete Mini Protease Inhibitor Cocktail tablet (Roche Diagnostics, Mannheim, Germany) and PhosSTOP phosphatase inhibitor tablet (Roche Diagnostics) and centrifuged at 10 000 g for 10 minutes at 4°C. To obtain separated protein fractions from cytoplasm and nucleus, respectively, NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Fisher Scientific) was used, according to manufacturer's instructions. Four wells were pooled for each time point to ensure sufficient amounts of cell extracts. The total protein amounts were measured using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
For each blot, 5 µg of total protein were loaded and separated by SDS-PAGE on 4-15 per cent Criterion TGX Stain-Free precast gels (Bio-Rad Laboratories). Next, gels were activated by exposing the gel to UV light in the ChemiDoc Touch imager (Bio-Rad Laboratories), obtaining the total protein assessment as a loading control, which allows the omission of the analysis of house-keeping proteins and proved to be a superior loading control in comparison to beta-actin (22) . For immunoblotting, the separated proteins were transferred to low-fluorescence PVDF membranes (Bio-Rad Laboratories), using the Trans-Blot Turbo Transfer System (Bio-Rad Laboratories). After blocking with Tris-buffered saline (TBS; Bio-Rad Laboratories), containing 0.2 per cent Tween (Sigma Aldrich), and 5 per cent bovine serum albumin (BSA; Sigma Aldrich) for 2 hours at room temperature (RT), membranes were incubated over night at 4°C with primary antibodies in TBS-Tween (1:5000), containing 0.5 per cent BSA. Membranes were rinsed 3 times for 15 minutes in TBS-Tween and incubated with horseradish peroxidase-labeled secondary antibody (1:5000; anti-rabbit or anti-mouse, depending on the primary antibody used; Li-Cor Biosciences, Homburg, Germany) for 1 hour at RT on a rocking platform. To ensure that equal total protein amounts were loaded, the membranes were imaged for total protein quantification with the stain free application method of the ChemiDoc Touch imager prior to chemiluminescent protein detection. The proteins of interest were detected, using the Clarity Western ECL Blotting Substrate (Bio-Rad Laboratories) and chemiluminescence application of the ChemiDoc Touch imager. For all investigated proteins, WB experiments were repeated in at least 3 independent experiments. The protein bands were normalized initially to total protein level in the respective sample in relation to the corresponding subfraction (either whole cell, cytoplasmic, or nuclear extract) and subsequently to the respective unstrained control with ImageLab software (version 5.2.1; Bio-Rad) and visualized as bar charts with GraphPad software (version 6.05; La Jolla, CA, USA).
Indirect immunofluorescence
After strain application, hPDLFs were fixed in 96 per cent ethanol (Sigma Aldrich) for 10 minutes on ice. Flexible membranes were cut in pieces and blocked in 5 per cent BSA (Sigma Aldrich) and 0.1 per cent Triton X-100 (Sigma Aldrich), diluted in PBS for 30 minutes. For antibody-treatment, cells were incubated for 1 hour at RT or over night at 4°C with primary antibodies diluted in PBS (1:200), containing 0.5 per cent BSA. Membranes were rinsed 3 times in PBS for 5 minutes, and subsequently incubated for 1 hour at RT with secondary fluorochrome-conjugated antibody (1:200; Alexa Fluor 594 goat anti-rabbit or anti-mouse IgG, depending on the primary antibody used, Thermo Fisher) and Alexa Fluor 488 phalloidin (1:50; Invitrogen) for actin cytoskeleton staining diluted in PBS containing 0.5 per cent BSA. After 3 washing steps with PBS for 5 minutes each, nucleus counterstain was carried out with DAPI staining (300 nM; Sigma Aldrich) for 10 minutes at RT. After 2 washing steps for 5 minutes with PBS and a final wash with distilled water, membrane pieces were embedded in mounting medium Fluoromount (SouthernBiotech, Birmingham, USA). Immunostaining was documented with Keyence BZ-9000 fluorescence microscope (KEYENCE GmbH, Neu-Isenburg, Germany). For documentation purposes, images were taken with a 60× oil-immersion objective under identical illumination and exposure time conditions within the experimental set up for each antibody. Exposure time for phalloidin and DAPI were varied if required to optimize image quality.
Semi-quantitative fluorescence intensity (SQFI), which has been successfully used in former studies in our lab (23) , was performed to measure relative mean pixel intensities of YAP fluorescence in the nucleus corresponding to YAP and RUNX2 protein expression in the cell nuclei. Therefore, cell nuclei were encircled in the DAPI channel with the magic wand tool in Photoshop (Adobe Systems, Delaware, USA) and masked in the channel corresponding to YAP antibody, so as to the fluorescence generated by YAP presence remained visible only in the nucleus. Next, these acquired images were imported into the image analysis software ImageJ (National Institutes of Health, USA). For analysis, each individual nucleus was circled as a Region of Interest and the mean fluorescence intensity was calculated for 80 to 100 nuclei for each treatment group. Fluorescence intensities were normalized to the maximum measured nuclear fluorescence for each time point, which was set to 100 per cent.
To prove the veracity of the nucleus-inherent YAP fluorescence, a Z-stack image was generated with BZ-II Analyzer (Keyence) exemplarily after 6 hours of static strain, displaying the cell nuclei in different spatial levels. Additionally pseudo-colour images for YAP fluorescence were generated, by importing the image into the image analysis software ImageJ and converting the channel's pixel intensity values corresponding to YAP fluorescence to pseudo-colour images. These pseudo-colour images show single pixel values ranging from 0 to 255, which in ascending order represent fluorescence intensities and thus the frequency of occurrence of an antigen in colours, ranging from black (pixel value = 0), to green colours (range: 65 to 128), and yellow to white colours (range: 128 to 255), with 255 referring to 100 per cent fluorescence signal intensity.
Statistical analysis
All experiments were performed in at least 3 biological replicates. GraphPad Prism software (v. 6, La Jolla, CA, USA) was used to perform statistical tests. Differences were analysed using one-way analysis of variance and Tukey's multiple comparisons test between all groups and were considered significant when P < 0.05.
Results
Strain-induced modulation of ERK1/2 in hPDLFs
As ERK1/2 represents a commonly known key player in mechanotransduction (11), we first analysed its total amount as well as activation state, in response to the applied static strain. WB analyses, performed against both ERK1/2 total ( Figure 1A ) and its phosphorylated and thus activated form (pERK1/2 T202/204; Figure 1B) , revealed an initial, clear decline in response to the applied static strain. For pERK1/2 T202/204 a mild recovery was detected after 6 hours of strain, which progressed at 24 hour of strain, thereby fairly reaching the level of unstrained controls ( Figure 1B ). Similar hereto, the level of ERK1/2 total showed a continual increase at the analysed time points, starting from 1 hour on ( Figure 1A ). In addition, IIF of pERK1/2 T202/204 ( Figure 1C) was performed, showing a matching configuration to WB analysis. The observed strain-modulated course of ERK1/2 points to an early drastic reduction of ERK1/2 total amount and activation upon the applied strain, while the later examined time points suggest a partial recovery.
YAP-targeted strain response identifies exclusive modulation of nuclear presence YAP is a mechanoresponsive molecule so far not investigated in hPDLFs (16) . This transcriptional co-activator is inactive in the cytoplasm and principally exerts its functions via dephosphorylation and translocation into the nucleus. Thus, both the phosphorylation status and subcellular localisation of YAP is crucial to evaluate its activity. Therefore, cytoplasmic and nuclear protein subfractions of hPDLFs were analysed separately from each other. WB analysis against YAP revealed two bands with different molecular weights (Figure 2A ). In the cytoplasmic fraction a single band with a molecular weight of 65 kDa was detected, while the nuclear extract exhibited an additional band with a molecular weight of 50 kDa. Concerning the strain application, the cytoplasmic fraction remained fairly constant in their band intensities, whereas the nuclear fraction revealed a modulation in the amount of YAP ( Figure 2B ). Compared to control cells and the 15 minutes strain period, a clear increase of nuclear YAP was detected at the later investigated time points. In agreement to WB analysis, this pattern of an early increase and a subsequent decline of nuclear YAP could also be observed in the performed IIF and the provided pseudo-colour images ( Figure 2C ). SQFI measurement ( Figure 2D ) revealed an increased nuclear YAP presence for early strain periods, which was followed by a subsequent decline. In case of 24 hours of strain, YAP fluorescence intensities within the nuclei were significantly lower compared to untreated controls and the earlier time points under study. Figure 2E shows a Z-stack image, illustrating that the detected YAP fluorescence veritably resides within the nucleus and does not represent a nuclear epifluorescence. In summary, the WB and IIF analyses revealed that the applied strain evoked a modulation of subcellular nuclear YAP presence, whereas the amount in the cytoplasm remained fairly constant.
Cell behavioural strain response implied modulation of proliferation
As the analysed mechanoresponsive molecules are known to be regulatory involved in cell behavioural processes, namely proliferation, we additionally analysed the effect of static strain on proliferation of hPDLFs (15, 24) . Both WB and IIF analyses demonstrated an increased protein amount of the marker of proliferation KI-67 in nuclear cell extracts at 15 minutes of strain, which was followed by a consecutive decrease at the subsequent strain periods (Figure 3) . The quantification of the number of proliferating cells in controls with matched strained cells revealed a slight proliferation increase at 15 minutes of static strain, followed by a progressive decline at the later periods ( Figure 3D ). This decrease of proliferating cells was proven to be significant by comparing the strain period of 15 minutes with that of 24 hours. To sum up, these observations point to a cell behavioural strain-responsive modulation of proliferation.
Discussion
OTM-induced biomechanical forces, acting on the periodontium, are perceived, transduced into intracellular signals, and converted into a behavioural response by mechanosensitive PDLFs (2) . Since the molecular constituents, which yield possible cell behavioural responses, are not fully elucidated, the present study aimed at identifying further key factors of mechanotransduction in hPDLFs. In this course of identification, our experiments showed a biomechanically induced strain modulation for all examined target molecules.
The observed modulations of our target molecules are discussed on the following and schematically iconized in Figure 4 . They are substantiated by a clear decrease in ERK1/2 total protein amount as well as ERK1/2 phosphorylation and thus activation level. Such a rapidly occurring modulation with emphasis on the activation level of ERK1/2 has been already described in various studies. For example, the application of 20 per cent static strain yielded an increased activation level of all three known MAPK, including ERK1/2, in mouse fibroblasts and human kidney-derived cells within the first 10 minutes of strain (25) . Similar observations with an increased early activation of ERK1/2 have been made in osteoblasts (13) . In contrast to these results, the early strain response in our study was characterized by a decreased total protein amount as well as activation level of ERK1/2. These opposing findings may be attributed to differences in the applied strain and/or the use of different cell types. Firstly, cyclic stretch of 0.4 per cent and static strain of 20 per cent were applied in the studies of Jansen and Sawada, respectively, whereas in the present study, cells were subjected to a static strain of 2.5 per cent. Secondly, the above-mentioned studies employed differentiated, i.e. confluent and/or post-confluent immortalized osteoblasts (13) , and immortalized mouse fibroblast (25) , respectively. On the contrary, we performed the experiments with primary cells derived from a human periodontal soft tissue, and cultured them up till reaching a pre-confluent stage, i.e. 70-80 per cent confluency.
Hence, it cannot be excluded that these species-specific differences may yield opposing cellular biomechanical strain responses. This assumption is corroborated by a study from Ziegler and colleague. In this study, similar to our findings, a down-modulation of ERK1/2 activation state in hPDLFs after 30 minutes of 2.5 per cent static strain was observed (20) . The fairly coinciding patterns observed for the strain-related modulation of ERK1/2 total and ERK1/2 activity in our study may be attributed to the observations published by Lefloch and colleagues, that the activation ratio of ERK1/2 in cells corresponds with their expression ratio, indicating that the isoforms are activated in parallel (26) .
In addition to the phosphorylation cascade of the MAPK pathway, the signal transduction cascade of the Hippo pathway with YAP as transcriptional co-activator was found to be involved in mechanotransduction (27, 28) . In its inactive state, phosphorylated YAP is bound to the 14-3-3 protein and thus retained in the cytoplasm (19) . Upon stimulation, through e.g. biomechanical strain, YAP becomes dephosphorylated and thus binding to the 14-3-3 protein is dissolved. Subsequently, the transcriptional co-activator translocates into the nucleus, where YAP regulates gene expression via binding to transcriptional enhancers (17, 24) . Hence, YAP localisation is crucial for its function, wherefore YAP presence in the cytoplasm and the nucleus was examined separately from each other. WB analysis of the cytoplasmic extract revealed fairly constant intensities of the protein bands in control as well as strained cells at all investigated time points. Although not directly proven, these protein bands, running at a molecular weight of 65 kDa, may correspond to phosphorylated YAP. This phosphorylation, occurring on five serine residues, is facilitated by the large tumour suppressor kinase of the Hippo pathway and is responsible for the binding to the 14-3-3 protein and thus retention in the cytoplasm (29) . By contrast, WB analysis of nuclear extracts showed a modulation of YAP quantity in response to strain, with increasing subcellular nuclear amount at the beginning, followed by a decrease at later time points. In the nuclear extract an additional protein band was detected, running at a molecular weight of 50 kDa. This band most likely reflects non-phosphorylated nuclear YAP, corresponding to the active state of this transcriptional co-activator, which regulates the expression of various genes (19) . The modulated course of nuclear YAP could also be confirmed in the performed IIF and the subsequent quantitative evaluation of nuclear YAP fluorescence. Based on these findings, it appears likely that nuclear YAP localisation and thus activity are responsive to strain.
Both ERK1/2 and YAP are known regulators of proliferation, the latter representing one of the potential behavioural responses of cells, subjected to biomechanical cues, including strain (30) (31) (32) . Interestingly, in response to the applied strain, the marker of proliferation KI-67 showed a modulation in its nuclear amount similar to the observed modulated course of nuclear YAP. In contrast hereto, the modulation of ERK1/2 total protein and its phosphorylation state and thus activity in response to the applied strain, seems to be opposed to the observed course of both nuclear YAP and KI-67. Therefore, the assumption seems reasonable that KI-67 expression and thus proliferation is mediated rather by the subcellular nuclear presence and thus activity of YAP than by ERK1/2, including both its activity and total protein amount. This finding leads to the presumption of a possible mechanistic interrelation between subcellular nuclear YAP presence and proliferation in strained hPDLFs. In analogy to our findings, a relation between YAP localisation/activation with nuclear KI-67 amount and thus proliferation in response to biomechanical deformation was also identified in a study with cancer cells, which revealed a clear connection between strain-modulated relocalisation of YAP into the nucleus and proliferation (24) . Moreover, another study by Kook and co-workers demonstrated in myoblasts an opposing modulation of ERK1/2 phosphorylation and proliferation in response to cyclic strain (33) . This supports our assumption that the observed strain-induced modulation in proliferation is independent from ERK1/2 activity and its total protein amount.
Interestingly, all target molecules showed clear modulations of their amount and/or activity at the early time points of the applied static strain, followed by a fairish return to the original state. This finding suggests that the observed response of hPDLFs to the applied biomechanical force may comprise an early reactive phase, followed by a later more adaptive phase. Change of the perspective from our in vitro approach to the clinical situation allows for the assumption that the strain-modulated course may share similarities to the course of OTM, which is divided into three phases: the initial phase, the lag phase, and the postlag phase (8, 34) . The initial phase occurs within 24 to 48 hours after the first application of biomechanical force to the tooth; a time frame which is in accordance with our straining periods. This phase is characterized by a rapid tooth movement, mainly attributed to the remodelling processes in the periodontal tissue (7) . With respect to clinics, the cell behavioural modulation of proliferation in response to strain, may contribute to these remodelling processes inside the PDL (7, 8) . The observed subsequent downmodulation of proliferation may be part of the cell adaptation to the applied strain. This could reflect the lag phase of OTM, showing relatively little to no tooth movement.
Limitations
Our results point to a relationship between YAP and proliferation in response to static strain, which will be scrutinized in consecutive experiments. Additionally, the observed modulations in our hPDLFs should only cautiously be assigned to in vivo studies and clinics.
Conclusion
In the present study, we detected for the first time a strain-evoked modulation of subcellular nuclear YAP presence in hPDLFs. The courses of modulation of ERK1/2 and YAP suggest a subdivision of the cellular strain response in an early reactive and a later adaptive phase. With respect to clinics, our strain evoked an initial increase of proliferation in hPDLFs during a time frame, comparable to the initial phase of OTM, which may contribute to PDL remodelling processes. Additionally, the observed concurrent course of KI-67 amount and subcellular YAP localisation supports the notion that the modulation of proliferation is mechanistically more likely regulated by YAP activity rather than by ERK1/2. Both proteins affect the cell behaviour to the mechanically applied strain, e.g. proliferation, via regulation of the gene transcription. In the present study, the observed modulation of the proliferation marker KI-67 showed the same trend as the modulation of nuclear YAP, suggesting an interrelationship between biological active YAP and proliferation.
